Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents
A phase 4 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 130 participants.
Also called NCT06718179
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 130 participants
- Sponsor
- Registry
-
NCT06718179 -
2024-515236-69-00
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Denmark
- Registry status
- Terminated
Technical summary
Registry record NCT06718179. Randomized; single masking; primary purpose treatment. Start 2024-11-16 (actual); primary completion 2025-05-25 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Short Versus 12 Months Prasugrel Plus Aspirin in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention and Everolimus-eluting Stents
- Acronym
- SORT OUT DAPT
- Condition
- Acute Coronary Syndrome
- Intervention (Drug)
- Short duration of aspirin and prasugrel
- Intervention (Drug)
- Conventional duration of aspirin and prasugrel
- Lead sponsor
- Odense University Hospital
Record details
- Record id
cardio:ct-nct06718179- Content hash
01af1d4ff937adfb7efc98eee91a49e9ad3bc9778b47c8466a3273625242864d